MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
The Role of Biophilic Design in Healthcare Facilities
Nature-inspired design can support staff well-being and create more welcoming, human-centered healthcare environments.
TriStar Centennial Medical Center Invests $90M in Women, Children's Hospital Expansions
The multi-year project will bring significant improvements to both hospitals.
Virginia Cancer Specialists to Open Newly Expanded Fauquier Location
The new Fauquier location will serve as a hub for clinical research and innovation in the future.
Emergency Preparedness: Building a Stronger Community
Professional memberships offer a convenient way to access practical resources, stay current on critical changes and learn from peers.
Ground Broken on Lavine Bekenstein Cancer Hospital in Massachusetts
The 450,000-square-foot facility will feature 300 inpatient beds across ten floors and has been designed specifically around the needs of people with cancer and their families.